Literature DB >> 6360404

Syntheses of hydroxyamino, nitroso and nitro derivatives of Trp-P-2 and Glu-P-1, amino acid pyrolysate mutagens, and their direct mutagenicities towards Salmonella typhimurium TA98 and TA98NR.

K Saito, Y Yamazoe, T Kamataki, R Kato.   

Abstract

Hydroxyamino, nitroso and nitro derivatives of 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) and 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1), mutagens-carcinogens produced on pyrolysis of amino acids, were synthesized from Trp-P-2 and Glu-P-1. 3-Hydroxyamino-1-methyl-5H-pyrido[4,3-b]indole (N-OH-Trp-P-2) and 2-hydroxyamino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (N-OH-Glu-P-1) were obtained with good yields by controlled catalytic reduction of 3-nitro-1-methyl-5H-pyrido[4,3-b]indole and 2-nitro-6-methyldipyrido[1,2-a:3',2'-d]imidazole. Subsequent oxidation of N-OH-Trp-P-2 and N-OH-Glu-P-1 with gamma-manganese dioxide yielded 3-nitroso-1-methyl-5H-pyrido[4,3-b]indole and 2-nitroso-6-methyldipyrido[1,2-a:3',2'-d]imidazole. All six synthesized compounds were mutagenic to Salmonella typhimurium TA98 without mammalian activation systems. The mutagenic activities of hydroxyamino and nitroso derivatives were identical for both S. typhimurium TA98 and TA98NR, the nitroreductase deficient strain. However, nitro derivatives were essentially mutagenic only towards S. typhimurium TA98.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6360404     DOI: 10.1093/carcin/4.12.1547

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  2 in total

1.  Generation of intracellular active oxygens in mouse FM3A cells by 3-hydroxyamino-1-methyl-5H-pyrido[4,3-b]indole, the activated Trp-P-2.

Authors:  Y Wataya; K Yamane; K Hiramoto; Y Ohtsuka; Y Okubata; K Negishi; H Hayatsu
Journal:  Jpn J Cancer Res       Date:  1988-05

2.  Metabolic activation of pyrolysate arylamines by human liver microsomes; possible involvement of a P-488-H type cytochrome P-450.

Authors:  Y Yamazoe; M Abu-Zeid; K Yamauchi; R Kato
Journal:  Jpn J Cancer Res       Date:  1988-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.